Long-term 3-year follow-up of mosunetuzumab in relapsed or refractory follicular lymphoma after ≥2 prior therapies - Sehn, Laurie H.; Bartlett, Nancy L.; Matasar, Matthew J.; Schuster, Stephen J.; Assouline, Sarit E.; Giri, Pratyush; Kuruvilla, John; Shadman, Mazyar; Cheah, Chan Yoon; Dietrich, Sascha; Fay, Keith; Ku, Matthew; et al. (Blood, 2025)
Gesehen am 15.09.2025